Skip to main content
. 2018 Aug 22;2:PO.18.00127. doi: 10.1200/PO.18.00127

Fig 1.

Fig 1.

Timeline of treatment and bone marrow blast percentages for patient 1. C, cycle; DexaM, dexamethasone; hyper-CVAD, hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and cytarabine; mini-CVD, dose-attenuated cyclophosphamide, vincristine, and dexamethasone alternating with methotrexate and cytarabine.